Clinical Trial Update: (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer

View source ↗

Summary

This clinical trial update discusses the use of the Oncotype DX genomic test in estrogen receptor-positive, HER2-negative breast cancer with 1-3 positive lymph …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Breast Cancer | Status: UNKNOWN